“We’ll add access control before launch” is one of the more expensive sentences in computational biology. Genomic data carries risk that generic access control models weren’t built for, and retrofitting the right model onto an existing schema is almost always slower — and riskier — than designing it in from the start.
Why genomic data breaks generic access control models
Most access control frameworks are built around a simple question: can this user see this record? Genomic data adds a second, harder question: can this user see this record in combination with these other records? Re-identification risk in genomic data often isn’t about any single field — it’s about what becomes identifiable once enough fields are combined, which a row-level permission check alone won’t catch.
On top of that, genomic platforms frequently span multiple contributing institutions, each with its own data-sharing agreement and consent terms. A permission model that treats “access” as a single binary flag can’t represent that a given user might be authorized to query aggregate statistics but not individual-level records, or authorized for one cohort but not another.
What we design in from the schema up
- Row- and column-level permissions mapped explicitly to each data-sharing agreement, not a single access tier for the whole dataset.
- De-identification and k-anonymity-style checks applied before data reaches a query layer, not left to the end user’s judgment.
- Full audit logging of every access, with enough context to answer “who saw what, and why” months later, not just at the moment of the query.
- Incident response playbooks written before launch, not assembled during an actual incident.
They found the gap our previous auditor missed twice — and told us exactly how to close it.
The cost of getting this right early
None of this is expensive to design in from the start. It becomes expensive, and risky, when it’s added after a schema and an application layer already exist and now need to be reworked around it. Every genomic data platform we’ve built treats access control as a first-class schema decision, made in week one, not a compliance task scheduled for the week before launch.